Bionaut Labs

Bionaut Labs

Growth Stage

Therapeutics Reimagined

Therapeutics Reimagined


Funding data not publicly available


Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common

SEC Filing Type

RegD 506(c)

Pre-Money Valuation


Year Founded



Healthcare & Pharmaceuticals

Tech Sector



Los Angeles, California

Bionaut Labs, with a valuation of $70 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company is reimagining therapeutics with its precision-targeted medicine and micro-robots. The micro-robot Bionauts are injected into the cerebrospinal fluid and guided magnetically to precise locations within the central nervous system. These Bionauts help in gene therapy, diagnostic payload, and other medications. Michael Shpigelmacher and Aviad Maizels founded Bionaut Labs in 2016. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $5,550,000. The campaign proceeds will be used for growth and expansion.
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Bionaut Labs on OurCrowd 2021
Platform: OurCrowd
Security Type: Equity - Common
Valuation: $70,000,000

Follow company

Follow Bionaut Labs on OurCrowd 2021

Buy Bionaut Labs's Deal Report

Warning: according to the close date for this deal, Bionaut Labs may no longer be accepting investments.

Bionaut Labs Deal Report

Get KingsCrowd’s comprehensive report on Bionaut Labs including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Bionaut Labs is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Bionaut Labs deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge